Pharma Voice’s 100 list is a prestigious compilation that recognizes influential leaders and innovators in the pharmaceutical and life sciences industry. Among the distinguished individuals acknowledged is Dr. Paul-Peter Tak, who has made significant contributions to Candel Therapeutics. Dr. Tak’s inclusion in the list is a testament to his impactful role in advancing the field of oncolytic viral immunotherapies. At Candel Therapeutics, Dr. Tak has played a pivotal role in spearheading groundbreaking approaches to cancer treatment, leveraging his extensive knowledge in viral immunotherapy and his wealth of clinical experience across diverse indications. This recognition highlights Dr. Tak’s exceptional leadership and the transformative impact of Candel Therapeutics in the realm of cutting-edge oncological solutions.
See PharmaVoice’s full 100 list here: https://www.pharmavoice.com/news/2021-07-pharmavoice100-whos-on-the-list-by-category/612028/
